Status:

ACTIVE_NOT_RECRUITING

Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction

Lead Sponsor:

University of Alabama at Birmingham

Collaborating Sponsors:

Bracco Corporate

Conditions:

Breast Benign Tumor

Breast Malignant Tumor

Eligibility:

FEMALE

18-99 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to evaluate the ability of AI to correctly aid in characterization of benign and malignant lesions even when a low dose of gadolinium is administered. This study is releva...

Detailed Description

The study involves each patient presenting for an initial MRI with a regular dose of gadolinium and then presenting at least 48 hours after (no less than 14 days later) for a ¼ dose (see below regardi...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Breast Cancer Patients:
  • Female patient between ≥ 18 years old and ≤ 99 years old
  • Patients with newly diagnosed primary breast cancer
  • Patient able and willing to participate in the trial
  • Inclusion criteria for Non-malignant indications:
  • Female patients between ≥ 18 years old and ≤ 99 years old
  • Be referred for MRI for non-malignant indications (screening or BIRADS 3)
  • Patients have had prior exam with known enhancing mass, nonmass enhancement, or focus/foci.
  • Exclusion Criteria:
  • Non-female patients
  • Patients \< 18 years old
  • Women who are lactating or pregnant
  • Patients with recurrent breast cancer
  • Patients who have already received neoadjuvant chemotherapy
  • Unable to lie still on the imaging table for one (1) hour
  • Patients that are unable to undergo MRI evaluation for reasons specific to MRI

Exclusion

    Key Trial Info

    Start Date :

    July 14 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 30 2025

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT04340180

    Start Date

    July 14 2021

    End Date

    December 30 2025

    Last Update

    October 3 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The Kirklin Clinic

    Birmingham, Alabama, United States, 35249